in vivo biosafety & potency testing
|
Prior to initiation of clinical trials, all biologics must undergo an extensive safety evaluation and a demonstration of potency. Charles River Biopharmaceutical Services (BPS) provides in vivo testing in our accredited in vivo biosafety (IVB) testing services laboratory according to Good Laboratory Practice (GLP) and current Good Manufacturing Practice (cGMP) guidelines. IVB testing includes mouse, rat and hamster antibody production; inapparent virus assay; tumorigenicity; and a range of general safety tests.
BPS is a leader in determining the potency of botulinum toxins and has extensive experience with vaccine challenge studies (e.g., Japanese Encephalitis Virus) and will have influenza challenge study capabilities in the near future.
BPS also has extensive experience in the area of in vivo immunogenicity and biological potency assay development, validation and implementation for neurotoxins, hormones, anti-venoms, vaccines and allergenic products. Oncogenicity studies on biologics are preformed by Charles River Preclinical Services.
For more information, please contact us at askcharlesriver@crl.com or 1.877.CRIVER.1.
|
in vivo biosafety testing, biosafety testing, potency assays, potency testing, IVB, IVB testing, mouse antibody production, rat antibody production, hamster antibody production, inapparent virus assay, tumorigenicity, in vivo immunogenicity, botulinum toxins, Japanese Encephalitis Virus, influenza challenge studies, Good Laboratory Practice, GLP, current Good Manufacturing Practice, cGMP
In vivo Biosafety & Potency Testing Services | Charles River
Charles River Biopharmaceutical Services (BPS) provides in vivo testing in our accredited in vivo biosafety (IVB) testing services laboratory according to Good Laboratory Practice (GLP) and current Good Manufacturing Practice (cGMP) guidelines.